Feed on
Posts
Comments
Fate Therapeutics Licenses Stem-Cell Modulators for Bone
GenomeWeb Daily News
Stem cell therapeutics company Fate Therapeutics said today that it has acquired from the University of California, Los Angeles,
Fate Therapeutics Granted Exclusive License By The Regents of the PR Newswire (press release)

all 8 news articles »

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Trackback URI | Comments RSS

Leave a Reply

General Health
Health Care
Nutrition
Personal Care
Sex and Sensuality
Bestsellers